Adnavance Technologies

Adnavance Technologies was a biotechnology company focused on the development of DNA-based nanotechnology for diagnostic and therapeutic applications. The company's core platform, known as M-DNA (metallized DNA), involved the site-specific incorporation of metal ions into the DNA double helix to create stable, conductive, and functionalized nanostructures. These M-DNA molecules were designed to serve as highly sensitive probes for molecular diagnostics, enabling the detection of specific genetic sequences with high precision. The company aimed to leverage the self-assembling properties of DNA to create a new class of biosensors and scaffolds for drug delivery. While the company explored various applications, its primary focus was on advancing its proprietary DNA-metal hybrid technology for infectious disease detection.